EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology

Felix Tobias Kurz

The Lancet Medical Imaging & Theranostics · 2026

DOI: 10.1016/j.lanmit.2026.100023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Lancet Medical Imaging & Theranostics, 2026. Verfasst von Felix Tobias Kurz. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kurz, F. T. (2026). Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology. The Lancet Medical Imaging & Theranostics. https://doi.org/10.1016/j.lanmit.2026.100023

Vancouver

Kurz FT. Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology. The Lancet Medical Imaging & Theranostics. 2026. doi:10.1016/j.lanmit.2026.100023

BibTeX
@article{Kurz2026,
  author = {Kurz, Felix Tobias},
  title = {Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology},
  journal = {The Lancet Medical Imaging & Theranostics},
  year = {2026},
  doi = {10.1016/j.lanmit.2026.100023}
}
Kostenlos starten →